Abnous Podia Invest&Architect Launches as an R&D Company Applying Formulation Tech to Biomaterials for Construction and Infrastructure

Abnous Podia Invest&Architect Inc. (Headquarters: Sumida-ku, Tokyo; Representative Director: Ryuto Kawamata; hereinafter "APIA") announces the commencement of its business operations as a research and development-oriented company. APIA promotes the R&D of biomaterials applying pharmaceutical formulation technology and their social implementation in the construction, infrastructure, and living space domains.

[Image caption: Scene from the "STUDIO 10X" Demo Day pitch on March 24, 2026 (Tokyo Innovation Base [TIB] / Chiyoda-ku, Tokyo)]

APIA was established on March 30, 2026, receiving startup support from "Studio 10X," an agreement project under the Tokyo Metropolitan Government's startup creation initiative "TOKYO SUTEAM." Starting from the construction and architecture sectors, the company is advancing material development and commercialization.

Currently, STUDIO 10X operates as "Studio 10x powered by BEXX & 01Booster," a program where aspiring entrepreneurs aim to create startups alongside venture studios by utilizing dormant opportunities within corporations. The targeted areas include construction/real estate, logistics, environment, and urban development.

## Background of Establishment

In the construction and infrastructure sectors, there is a demand for the development of new materials that simultaneously satisfy reduced environmental impact, resource circulation, durability, workability, and designability.

On the other hand, advanced materials and research seeds face the challenge of not being widely adopted in society unless they overcome multiple hurdles: performance verification, mass production, regulatory compliance, sales channels, and implementation at construction sites.

APIA applies the formulation technologies cultivated in the pharmaceutical and medical device fields—specifically, technical concepts such as DDS (Drug Delivery System), sustained release, environmental responsiveness, and texture control—to the material development of building, civil engineering, and infrastructure materials.

Going beyond the mere R&D of the materials themselves, the company comprehensively envisions application design, manufacturing processes, intellectual property creation, licensing, and sales strategies, thereby connecting research seeds to products that are actually used.

## From STUDIO 10X Selection to Present

STUDIO 10X is a program where major companies in the construction, logistics, environment, real estate, and urban development sectors provide dormant corporate opportunities (opportunity for issue exploration/hypothesis testing, specialized knowledge/networks, and other tangible/intangible resources) to aspiring entrepreneurs participating in the program.

Through the startup support at STUDIO 10X, APIA refined its vision for a material development business in the architecture and construction fields, and proceeded with corporate establishment, business hypothesis verification, and partner exploration.

Currently, utilizing the hypothesis testing opportunities in the architecture and construction fields obtained through the program, APIA is advancing multiple pipelines including biomaterials, wood modification, upcycling of unused resources, naturally derived adhesives, and microbial preparations.

## Business Domains Addressed by APIA

APIA is deploying the following three areas as its core businesses:

1. Advanced Biomaterials
Conducts the R&D and supply of high-function biomaterials. Anticipating not only performance but also mass-producibility, architectural implementation, and international expansion potential, the company advances planning and development calculated backward from the exit products and sales strategies.

2. Material Licensing
Undertakes the IP creation and licensing rollout of material technologies. Rather than just exporting products, APIA aims to package manufacturing methods and processes to build technology transfers and licensing models with domestic and international manufacturing and sales partners.

3. Project Development
Comprehensively promotes everything from the selection of material development and technology seeds to the design of viable business plans, profit-sharing schemes, and co-creation projects.

## Ongoing Development Themes

Currently, APIA is advancing the development of the following material and product themes:

- Non-combustible and Water-resistant Wood
A composite wood material aiming to impart functions such as non-combustibility, water resistance, anti-mold properties, termite resistance, and weatherability by impregnating functional materials inside the wood.

- Biomaterial Wallpaper
Advancing the development of non-petroleum-dependent and low-environmental-impact architectural interior/exterior materials utilizing unused biomass and fermentation technologies.

- Naturally Derived Adhesives
Working on the development of naturally derived adhesives equipped with water resistance and preservative properties while upcycling unused resources such as skim milk powder.

- Bio-deodorants and Microbial Preparations
Advancing the development of materials and products that contribute to solving issues in living and industrial spaces by utilizing beneficial bacteria and their secreted components.

## Representative's Comment

Ryuto Kawamata, Representative Director, Abnous Podia Invest&Architect Inc.

"APIA aims to connect excellent material technologies lying dormant in laboratories and as technology seeds to products that are actually used in construction, infrastructure, and living spaces.

Advanced materials will not be socially implemented simply because of high performance. By simultaneously designing mass production, regulations, construction, sales, and partnerships, we elevate the probability that the technology will reach the market."